AOD-9604

Price range: $59 through $69

2MG, 5MG

AOD-9604 is dosed at 300 mcg–500 mcg daily via subcutaneous injection in educational protocols. A 2 mg vial reconstituted with bacteriostatic water yields about 0.667 mg/mL. This information is for research and educational use only.

In stock   |   ≥99% catalog purity

SKU: N/A Category:

Description

Product specification

Analytical Profile

Catalog data is presented for material identification and laboratory planning. Batch-specific documentation governs the supplied vial.

RESEARCH NAME AOD-9604 · Peptide Fragment 176–191
FORMAT Lyophilised powder
MOLECULAR FORMULA C209H322N54O64
MOLECULAR MASS 1815.1 g/mol
CAS REGISTRY 221231-10-3
ANALYTICAL IDENTITY HPLC 98.6% · LC–MS confirmed
CATALOG CONDITION Lyophilised · −20°C

PROTOCOL LITERACY

Reconstitution Sequence

This sequence uses a 2 mg vial reconstituted with 3.0 mL of bacteriostatic water, giving an approximate concentration of 0.667 mg/mL. Follow the supplied product instructions for preparation and storage.

01

Metabolic

Prepare 1.0 mL of bacteriostatic water with sterile equipment.

02

INTRODUCE SLOWLY

Direct the liquid toward the inside wall of the vial to limit foaming.

03

DISSOLVE GENTLY

Roll or swirl with care until the material is dissolved; do not shake.

04

LABEL AND PROTECT

Record the preparation date and keep the vial protected from light.

05

COLD STORAGE

Refrigerate at 2-8°C and use within the four-week reference window.

UNRECONSTITUTED MATERIAL

-20°C

Keep frozen, dry, sealed, and protected from direct light. Minimise exposure to moisture.

After reconstitution

2-8°C

Keep refrigerated after reconstitution and protect from unnecessary temperature changes.

Handling principle

DO NOT FREEZE

Avoid repeated freeze–thaw cycles and maintain appropriate refrigerated storage after reconstitution.

PROTOCOL LITERACY

AOD-9604 DOSAGE CHART

A source-derived reference covering concentration, gradual daily dosing, reconstitution, storage, and handling context. It is educational material—not an individualized regimen.

VIAL CONTENT

5 MG

+

REFERENCE DILUENT

3.0 MG

=

STOCK CONCENTRATION

1.667 MG/ML

U-100 SCALE

1 UNIT = 0.01 ML = 16.67 MCG

01

GRADUAL 8MG MODEL

02

12 MG TRIAL CONTEXT

EDUCATIONAL REFERENCE

GRADUAL DAILY MODEL

STUDY INTERVAL STAGE WEEKLY DOSE U-100 REFERENCE SOLUTION VOLUME
01 WEEKS 1-4
INITIATION 300 MG 18 UNITS 0.18 ML
02 WEEKS 5-12
MAINTENANCE 500 MCG 30 UNITS 0.30 ML

01

REFERENCE ASSUMPTIONS

Every unit and volume value shown assumes a 10 mg vial prepared to a total reference volume of 1.0 mL.

02

MATERIAL BOUNDARY

This table does not provide preparation or administration instructions.

03

PROTOCOL CONTROL

Trial documentation and qualified clinical oversight—not this chart—must govern all dosing decisions.

Product Enquiry

Have a question about this product? Send us your enquiry and our team will get back to you shortly.

Enquire Product